Time Is Critical with Glioblastoma
Glioblastoma has a median survival of 12-18 months with treatment. Filing your VA claim immediately upon diagnosis is essential — the 100% rating is retroactive to the date of diagnosis only if you file within one year. Do not delay. If your loved one has been diagnosed, help them file today.
The Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act — universally known as the PACT Act — is named for an Ohio Army National Guard soldier who embodied the fight for veterans' burn pit benefits. Sergeant First Class Heath Robinson deployed to Kosovo and Iraq, where he was routinely exposed to burn pit smoke and other toxic airborne hazards at forward operating bases.
After returning home, SFC Robinson was diagnosed with a rare blood cancer. His condition deteriorated over years as he fought — simultaneously — for his health and for the hundreds of thousands of veterans suffering from toxic exposure-related illnesses who were being denied VA benefits. He testified before Congress. He marched in Washington. He advocated with the same sense of mission he brought to his deployments.
SFC Heath Robinson died on May 26, 2020, at age 39, before the law bearing his name was signed. The PACT Act was signed into law by President Biden on August 10, 2022. For veterans with glioblastoma and other cancers linked to toxic military exposure, it is the most significant legislative achievement in decades — and a direct consequence of SFC Robinson's sacrifice.
The link between glioblastoma and toxic chemical exposure — including compounds found in burn pit emissions (polycyclic aromatic hydrocarbons, benzene, formaldehyde, heavy metals) — is part of the scientific basis for including brain cancers in the PACT Act's presumptive list. While GBM's exact etiology remains an area of active research, the PACT Act reflects Congress's determination that veterans exposed to these hazards in combat zones deserve presumptive coverage without having to prove individual causation.
Glioblastoma multiforme (WHO Grade IV glioma) is a malignant brain tumor arising from astrocytes — the supportive glial cells of the brain. Under the PACT Act's framework, all malignant neoplasms — including glioblastoma — are covered for veterans with qualifying toxic exposure in covered service locations.
The PACT Act amended title 38 of the United States Code to create a presumption of service connection for cancer in veterans with toxic exposure during covered service. For glioblastoma, this means:
For veterans whose GBM is not covered by the PACT Act presumptive (e.g., those who served exclusively before Gulf War era in non-qualifying locations), direct service connection via documented occupational exposure to chemicals — solvents, radiation, petrochemicals — is a viable alternative pathway under 38 CFR § 3.303. A nexus letter from a neuro-oncologist would be required for that pathway.
| Location | Qualifying Period |
|---|---|
| Southwest Asia (Iraq, Kuwait, Saudi Arabia, Bahrain, Qatar, UAE, Oman, Jordan, Egypt, Turkey, Syria, Israel, Lebanon) | August 2, 1990 – present |
| Afghanistan | September 19, 2001 – present |
| Djibouti, Africa | September 19, 2001 – present |
| Somalia or approaches | September 19, 2001 – present |
| Uzbekistan | September 19, 2001 – December 31, 2005 |
| Any location with documented burn pit, chemical, or airborne hazard exposure | Per VA determination |
A veteran needs to have served in any of these locations for any length of time — even temporary duty — to qualify for the presumptive. The DD-214, deployment orders, campaign medals, and unit records all serve as documentation of qualifying service.
VA rates glioblastoma under Diagnostic Code 8002 — Malignant neoplasms, brain — in 38 CFR Part 4. The rating is straightforward in its structure:
| Status | Rating | Basis |
|---|---|---|
| Active GBM under treatment (surgery, radiation, chemotherapy, immunotherapy, clinical trials) | 100% | 38 CFR § 4.117, Note to DC 8002 |
| GBM with neurological residuals (if disease could be controlled) | Rate by neurological residuals | Applicable neurological DCs |
| Recurrent or progressive GBM | 100% (continuous) | 38 CFR § 4.117 |
In practice, glioblastoma is nearly always fatal and treatment is continuous. The Stupp protocol — the standard of care for newly diagnosed GBM — involves surgical resection followed by concurrent radiotherapy (60 Gy over 6 weeks) and temozolomide chemotherapy, followed by 6-12 cycles of adjuvant temozolomide. After initial treatment, tumor recurrence is essentially universal, and subsequent treatment lines (bevacizumab, re-irradiation, tumor treating fields [TTFields], clinical trials) continue until death.
This means the 100% rating under DC 8002 typically remains in effect for the remainder of the veteran's life, because treatment never truly ends with GBM. The six-month post-treatment review period that applies to other cancers rarely becomes relevant for GBM patients, because there is rarely a period where all active treatment has ceased.
Glioblastoma and its treatment commonly cause secondary neurological disabilities that are separately ratable:
Beyond the 100% disability rating, veterans with glioblastoma often qualify for Special Monthly Compensation (SMC) — additional tax-free monthly payments above the standard 100% rate. SMC is available when specific conditions are met, and GBM frequently satisfies multiple SMC criteria:
SMC at the "L" rate (aid and attendance) is awarded when a veteran requires the regular aid and attendance of another person due to disability. The criteria include needing assistance with activities of daily living — bathing, dressing, feeding, ambulation. As glioblastoma progresses, patients typically require substantial assistance with daily activities. SMC-L is appropriate when these needs are documented by a physician or VA examiner.
In 2026, SMC-L pays approximately $3,800-$4,000 per month above the 100% rate, representing a substantial increase in total compensation.
SMC at the "S" rate applies when a veteran is substantially confined to their home due to service-connected disability. If GBM has progressed to the point where the veteran cannot leave the home without substantial assistance, SMC-S applies. SMC-S adds approximately $390/month above the 100% rate.
If GBM causes loss of use of one or both hands (affecting the dominant hand is rated at a higher level), loss of use of both feet, or loss of use of other major body parts, additional SMC levels apply. These are rated under 38 U.S.C. § 1114(k)-(r) and can significantly increase the monthly compensation amount.
VA is supposed to evaluate SMC eligibility automatically when a veteran has conditions that may qualify. In practice, SMC is frequently overlooked or not claimed. Veterans with GBM should specifically state in their claim: "I am requesting evaluation for Special Monthly Compensation based on [need for aid and attendance / housebound status / loss of use of ___]." A written request ensures VA must address it.
At 100% disability rating for GBM, a veteran already receives the maximum schedular rating and corresponding compensation. However, TDIU is still relevant in one critical scenario: if GBM is not yet rated at 100% (for example, if the veteran's claim is pending and they're still at a lower rating), TDIU can pay at the 100% rate if the veteran cannot work due to GBM.
More practically, TDIU matters for veterans who have GBM as a service-connected condition at 100% but have other non-service-connected conditions that might be evaluated differently. The overall impact is that TDIU ensures veterans who cannot work receive the maximum rate without waiting for the rating schedule to catch up.
For GBM patients, the practical reality is that the disease itself makes continued employment impossible almost immediately after diagnosis. TDIU criteria — substantially gainful employment is not possible due to service-connected disabilities — are clearly met. VA should grant TDIU (or the equivalent 100% schedular rating) promptly.
For many families of veterans with glioblastoma, the most important aspect of VA benefits is what happens after the veteran dies. Dependency and Indemnity Compensation (DIC) is a tax-free monthly benefit paid to surviving spouses, dependent children, and in some cases parents of veterans who die from service-connected conditions.
A surviving spouse is eligible for DIC if:
Given that GBM is fatal and is service-connected under the PACT Act, the death from GBM automatically makes the surviving spouse eligible for DIC. In 2026, the base DIC rate for surviving spouses is $1,562.74 per month. Additional amounts are paid for dependent children, and an 8-year transitional benefit adds $318.33/month if the veteran was rated at 100% for at least 8 continuous years before death.
| Additional DIC Benefit | Monthly Amount (2026 approx.) | Eligibility |
|---|---|---|
| Aid and Attendance allowance | +$350/month | Surviving spouse requires aid and attendance |
| Transitional benefit (8-year rule) | +$318/month for 2 years | Veteran rated 100% for 8+ continuous years |
| Each dependent child under 18 | +$400+/month per child | Dependent children |
If a veteran filed a VA claim for GBM but died before VA processed the claim or awarded compensation, the surviving spouse (or other eligible beneficiary) can file an accrued benefits claim under 38 CFR § 3.1000. Accrued benefits allow the surviving spouse to "step into the shoes" of the veteran and claim the compensation owed to the veteran during their lifetime that was not paid due to the pending claim. This can represent months or years of retroactive 100% compensation — a significant amount.
After a veteran dies from service-connected glioblastoma, the surviving spouse should file for DIC (VA Form 21P-534EZ) within one year of death. Additionally, file an accrued benefits claim if the veteran had a pending VA claim at death. The effective date for DIC is the date of the veteran's death if filed within one year — every month of delay reduces the retroactive payment.
The timeline with glioblastoma is compressed. Most patients have 12-18 months from diagnosis to death. VA claims can take months to process. Every week matters. The filing strategy for GBM veterans must reflect this urgency:
File VA Form 21-526EZ as soon as you have the pathology report. You can file online at va.gov, by mail, or in person at a VA regional office. If you're too ill to manage the paperwork, a family member with power of attorney can file on your behalf. A VSO (Veterans Service Organization) can assist with expedited filing.
VA has a compassionate allowance / rapidly progressing terminal illness program. Glioblastoma qualifies as a terminal illness for expedited processing. Write "TERMINAL ILLNESS — EXPEDITE" on your claim form and cover letter. VA is required to prioritize terminal illness claims. In some cases, VA can process these claims in days rather than months.
At the time of initial filing, list every disability related to the GBM: the cancer itself, seizures, hemiparesis, cognitive impairment, aphasia — and specifically request SMC evaluation. Doing this on the initial claim prevents you from having to file multiple supplemental claims later.
While the veteran is still alive, help prepare the DIC paperwork so the surviving spouse can file within days of the veteran's death. Gather the documents listed above. Know the DIC filing process. The sooner DIC is filed after death, the sooner monthly payments begin.
For additional context on the PACT Act's scope, see our guide on PACT Act presumptive conditions and our resource on burn pit exposure VA claims. Veterans who have lost a family member to cancer from toxic exposure should also review our related guides on lung cancer VA claims for additional DIC strategies.
Need Help Filing an Urgent GBM Claim?
REE Medical provides urgent nexus letter services for terminal illness claims. If the PACT Act presumptive doesn't apply to your service, or if you need to document neurological residuals for SMC consideration, their oncology-affiliated providers can help.
Explore REE Medical's Urgent/Terminal Illness Services →claim.vet may receive a referral fee if you use this link. Veterans never pay more.
Editorial Standards: Written by Marcus J. Webb, veterans benefits researcher. Verified against current 38 CFR regulations and PACT Act guidance. Last reviewed: July 2026. Not legal advice — for representation, connect with a VA-accredited attorney.
Glioblastoma is a terminal illness — VA has expedited processing for terminal claims. Don't wait. Start your free review now.
Start My Free Claim Review — No Phone Required →